Media-OutReach Newswire Zuellig Pharma Strengthens Consumer Healthcare Portfolio with the Acquisition of Zam-Buk® and Vapex® Brands from Bayer
Việt Nam's first patient with systemic lupus erythematosus recovers thanks to CAR-T immune cell therapy 3.